DENSITY HETEROGENEITY OF EOSINOPHIL LEUKOCYTES - INDUCTION OF HYPODENSE EOSINOPHILS BY PLATELET-ACTIVATING FACTOR
- 1 September 1989
- journal article
- research article
- Vol. 68 (1) , 140-143
Abstract
We have examined the induction of hypodense eosinophila by platelet-activating factor (PAF), a mediator which may be involved in eosinophil activatoin in allergic diseases. Guinea-pig eosinophils were incubated with buffer or PAF and applied to continuous Percoll density gradients. Cellular density ranged from 1.0142 to 1.1369 g/ml. Peak eosinophil density in control was 1.0887 .+-. 0.0008 g/ml (mean .+-. SEM), and 91.1 .+-. 1.4% of eosinophils were distributed between 1.0810 and 1.1000 g/ml. Preincubation of eosinophils with PAF(10-7 M) resulted in a time-dependent and non-cytolytic increase of the number of hypodense eosinophils, with peak densities after incubation for 1 hr and 2 hr of 1.-834 .+-. 0.0014 (n = 4, P < 0.05) and 1.0755 .+-. 0.007 g/ml (n = 6, P < 0.01), respectively. After incubation for 2 hr, 82.0 .+-. 4.9% (n = 6) eosinophils showed a density lower than 1.080 g/ml. Lyso-PAF, the inactive precursor and metabolite of PAF, at a concentration of 10-7 M had no effect on cell density. The specific PAF receptor antagonist WEB 2086 (10-6 M) inhibited the PAF-induced density shift by 87.0 .+-. 5.3%. Our results demonstrate that a single mediator is able to induce the formation of hypodense eosinophils. We conclude that the appearance of hypodense eosinophils in allergic diseases such as asthma may occur, at least in part, in response to inflammatory mediator which activate these cells.This publication has 24 references indexed in Scilit:
- PAF-Receptors on eosinophils: identification with a novel ligand, [3H]WEB 2086Biochemical Pharmacology, 1989
- Characterization of platelet‐activating factor‐induced elevation of cytosolic free calcium concentration in eosinophilsFEBS Letters, 1989
- Hypodense eosinophils in allergic rhinitisJournal of Allergy and Clinical Immunology, 1988
- Platelet-activating factor as a mediator of allergic diseaseJournal of Allergy and Clinical Immunology, 1988
- The presence of hypodense eosinophils and diminished chemiluminescence response in asthmaJournal of Allergy and Clinical Immunology, 1988
- Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts.The Journal of Experimental Medicine, 1987
- Leukotriene C4 production by normal-density and low-density eosinophils of atopic individuals and other patients with eosinophilia1Journal of Allergy and Clinical Immunology, 1987
- Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.Journal of Clinical Investigation, 1986
- Platelet-activating factor (PAF-acether) induced leukotriene C4 formation and luminol dependent chemiluminescence by human eosinophilsPharmacological Research Communications, 1986
- Heterogeneity of Human Peripheral Blood Eosinophils: Variability in Cell Density and Cytotoxic Ability in Relation to the Level and the Origin of HypereosinophiliaInternational Archives of Allergy and Immunology, 1983